文献速递甲状腺与浅表US

粗针活检在诊断滤泡型肿瘤中诊断率优于细针穿刺:一项以Bethesda IV结果为重点的多中心研究

Superior Diagnostic Yield of Core Needle Biopsy Over Fine Needle Aspiration in Diagnosing Follicular-Patterned Neoplasms: A Multicenter Study Focusing on Bethesda IV Results.
PubMed 文献 · Korean J Radiol · 2025-04-17

该多中心回顾性研究纳入韩国26家医院5463个≥1 cm甲状腺结节,比较粗针活检与细针穿刺以Bethesda IV为阳性标准诊断滤泡型肿瘤的诊断率。粗针活检诊断率在匹配前和匹配后均显著高于细针穿刺(9.0% vs 0.5%和9.0% vs 0.6%,P<0.001),假转诊率无显著差异(0.4% vs 0.1%,P=0.337),两种方法阳性预测值均持续大于90%且无显著差异。

要点

  • 以Bethesda IV为阳性标准,粗针活检诊断滤泡型肿瘤的诊断率显著高于细针穿刺。
  • 匹配后粗针活检与细针穿刺的假转诊率无显著差异(0.4% vs 0.1%,P=0.337)。
  • 两种方法阳性预测值均持续大于90%,无显著差异。

核心结论

  • 粗针活检对滤泡型肿瘤的诊断率高于细针穿刺,以Bethesda IV为阳性标准时假转诊率无显著差异。

研究设计与样本

  • 回顾性研究,纳入韩国26家医院2015年6月至9月间5463个≥1 cm甲状腺结节(4883例患者,女4019例、男864例,平均年龄53.8岁),细针穿刺或粗针活检后以手术病理为最终诊断;匹配前粗针活检823个结节、细针穿刺4640个结节,按年龄、性别、结节大小和K-TIRADS分类1:2匹配后分别为799个和1571个结节。

诊断标准与关键数值

  • 以活检结果为Bethesda IV(滤泡型肿瘤)作为检测阳性标准,诊断率定义为活检后手术证实为滤泡型肿瘤的结节占所有活检结节的比例;匹配前粗针活检9.0% vs 细针穿刺0.5%(P<0.001),匹配后粗针活检9.0% vs 细针穿刺0.6%(P<0.001);匹配后假转诊率粗针活检0.4% vs 细针穿刺0.1%(P=0.337);两种方法阳性预测值均持续大于90%且无显著差异。

临床应用与阅片要点

  • 在评估滤泡型肿瘤时,以Bethesda IV为阳性标准,粗针活检的诊断率高于细针穿刺,假转诊率无显著差异,两种方法阳性预测值均持续大于90%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the diagnostic outcomes of core needle biopsy (CNB) and fine-needle aspiration (FNA) using Bethesda IV as a test-positive criterion for diagnosing follicular-patterned neoplasms in a large multicenter cohort.

MATERIALS AND METHODS: This retrospective study included 5463 thyroid nodules ≥1 cm from 4883 patients (4019 females, 864 males; mean age 53.8 years) that underwent FNA or CNB across 26 hospitals in Korea between June and September 2015. The final diagnosis in cases diagnosed as Bethesda IV (follicular neoplasm) in biopsies were confirmed by surgical pathology. The primary study outcome was the diagnostic yield, defined as the proportion of nodules with follicular-patterned neoplasms confirmed at surgery after receiving Bethesda IV results on biopsy (FNA or CNB), among all that underwent biopsy. Secondary outcomes included false referral rate (FRR) and positive predictive value (PPV). All nodules were analyzed before matching (823 and 4640 nodules for CNB and FNA, respectively) and after nodule matching in a 1:2 ratio (799 and 1571 nodules, respectively) according to age, sex, nodule size, and Korean Thyroid Imaging Reporting and Data System (K-TIRADS) category. Additionally, the diagnostic yields of various histological subtypes of follicular-patterned neoplasms and nodule subgroups were analyzed.

RESULTS: CNB demonstrated a significantly higher diagnostic yield than FNA both before (9.0% vs. 0.5%; P < 0.001) and after matching (9.0% vs. 0.6%; P < 0.001). CNB consistently had higher diagnostic yields than FNA for most histological subtypes and all subgroups. FRR was not significantly different between the CNB and FNA groups after matching (0.4% vs. 0.1%; P = 0.337). The PPV was consistently greater than 90% for both methods, with no significant difference.

CONCLUSION: CNB had a higher diagnostic yield than FNA for follicular-patterned neoplasms, with no significant difference in FRR using Bethesda IV as the test-positive criterion.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Joo L, Baek JH, Lee J, et al. Superior Diagnostic Yield of Core Needle Biopsy Over Fine Needle Aspiration in Diagnosing Follicular-Patterned Neoplasms: A Multicenter Study Focusing on Bethesda IV Results. Korean J Radiol. 2025. PMID: 40288894. doi:10.3348/kjr.2024.1022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。